Cargando…
HIV Infection-Associated Frailty: The Solution for Now Is Antiretroviral Drugs: A Perspective
This Perspective article provides a new view of frailty as it relates to HIV-1 infection. We discuss new findings and where our research is going.
Autores principales: | Klotz, Stephen A., Bradley, Nicole, Smith, Shannon, Ahmad, Nafees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748472/ https://www.ncbi.nlm.nih.gov/pubmed/30803299 http://dx.doi.org/10.1177/2325958219831045 |
Ejemplares similares
-
Phenotypic frailty in people living with HIV is not correlated with age or immunosenescence
por: Klotz, Stephen A., et al.
Publicado: (2022) -
Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy
por: Behrens, Nicole E., et al.
Publicado: (2018) -
Evaluation of HIV-specific T-cell responses in HIV-infected older patients with controlled viremia on long-term antiretroviral therapy
por: Behrens, Nicole E., et al.
Publicado: (2020) -
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
por: Rees, Hilary C., et al.
Publicado: (2013) -
Impact of Antiretroviral Therapy on Intestinal Lymphoid Tissues in HIV Infection
por: Veazey, Ronald S, et al.
Publicado: (2006)